Educational corner

January 31, 2024


Adacolumn®: Fostering Synergies, Reducing Risks

Dr. Rodríguez-Lago shares existing evidence of the crucial role played by innate immunity in the pathogenesis of Inflammatory Bowel Disease (IBD), as well as in the failure of advanced therapies such as biologic drugs and small molecules. Hence, the combined use of granulocyte and monocyte apheresis (GMA, Adacolumn®) targeting mainly innate IBD trigger cells, such […]

role of GMA in IBD

February 6, 2023


The role of therapeutic apheresis in the management of IBD

The main objectives of this webinar are: clarify what is needed to have the best treatment outcome for IBD patients, how to help them maintain control of their disease and how Adacolumn’s mechanism of action might contribute to achieving both, alone or in combination with other therapies. Dr. Alessandro Mazzoni. (A.O.U. Pisana) Dra. Irene Bianco. […]

April 26, 2022


GMA use in paediatric IBD patients: Real world experiences (in English)

The paediatric inflammatory bowel disease (IBD) can cause malnutrition and growth retardation. Patients with IBD will require life-long treatment but can be limited by the potential adverse events of corticosteroids and anti-TNF agents in children as well as secondary loss of response (LoR) and drug dependence can occur at some time during the lifetime. Experience […]

September 9, 2021


Pediatric patient: Does the ideal target in UC treatment exist? (in Spanish)

Unique considerations when treating children and adolescents with IBD include attention to the effects and risks of the treatments on growth and development, bone health, and psychosocial functioning. New alternatives of treatment still are needed in this context for safer and longer outcomes. The benefits of using steroids, immunosuppressants or biologics need to be carefully […]

September 8, 2021


Does the ideal target in UC treatment exist?

While there is no known cure for ulcerative colitis and flare ups may recur, optimal treatment option can help patient stay in control of their disease and lead a full and rewarding life. The primary goal in treating ulcerative colitis is to help patients regulate their immune system better. Nevertheless, current approved treatments don’t work […]

Contact UsFor more information

Contact Us